Author:
Portseva T. N.,Kotnova A. P.,Bulavkina E. V.,Makarova A. A.,Georgieva S. G.,Stepchenko A. G.,Pankratova E. V.
Subject
Structural Biology,Biophysics
Reference32 articles.
1. Sytina E.V., Pankratova E.V. 2003. Transcription factor Oct-1: plasticity and multiplicity of functions. Mol. Biol. (Moscow). 37, 637–648.
2. Shakya A., Goren A., Shalek A., German C.N., Snook J., Kuchroo V.K., Yosef N., Chan R.C., Regev A., Williams M.A., Tantin D. 2015. Oct1 and OCA-B are selectively required for CD4 memory T cell function. J. Exp. Med.
212, 2115–2131.
3. Pankratova E.V., Stepchenko A.G., Krylova I.D., Portseva TN., Georgieva S.G. 2018. The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells. Oncotarget. 9, 29892‒29905.
4. Pankratova E.V., Stepchenko A.G., Portseva T., Mogila V.A., Georgieva S.G. 2016. Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt’s lymphoma cells affect a wide range of cellular processes. Nucleic Acids Res. 44, 9218‒9230.
5. Maddox J., Shakya A., South S., Shelton D., Andersen J.N., Chidester S., Kang J., Gligorich K.M., Jones D.A., Spangrude G.J., Welm B.E., Tantin D. 2012. Transcription factor Oct1 is a somatic and cancer stem cell determinant. PLoS Genet.
8, e1003048.